Ernexa Therapeutics Inc (ERNA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ERNA Annual Balance Sheets →
This page allows investors to track Ernexa Therapeutics Inc's balance sheet development across multiple reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent5.03
Cash & Short-term Investments5.00
Other Receivables, Net, Current0.00
Other Current Assets0.08
Prepaid Expense And Other Assets Current0.78
Total Current Assets5.89
Equipment/Property/Plant Net0.08
Goodwill net0.00
Other Assets, Noncurrent0.34
Operating Lease Right Of Use Asset0.35
Total Assets6.32
Liabilities
Accounts Payable, Current AC1.38
Accrued Liabilities, Current AC1.02
Other Liabilities, Current0.54
Taxes Payable, Current, Total0.00
Business Combination, Contingent Consideration, Liability, Current BU0.00
Total Current Liabilities2.93
Total Long-term Debt0.00
Other liabilities, Noncurrent0.18
Operating Lease Liability Current0.16
Operating Lease Liability Noncurrent0.23
Total Liabilities3.12
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock258.35
Retained Earnings / Accumulated Deficit-255.16
Other Equity0.00
Common Stockholder's Equity3.04
Preferred Stockholder's Equity0.16
Total Stockholder's Equity3.20
Liabilities & Stockholder's Equity6.32
4 historic quarters locked

Sign in to unlock the full Ernexa Therapeutics Inc balance sheet history.

About Ernexa Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 6, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-036424

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.